pharmaceuticals-and-healthcare

United States Recombinant Protein Market Report 2016


Published On : Oct 2016

Category : Biotechnology

No. of Pages : 124 pages

  • $3800
  • $7600

Please click below to avail discount on this report

Notes:
Sales, means the sales volume of Recombinant Protein
Revenue, means the sales value of Recombinant Protein

This report studies sales (consumption) of Recombinant Protein in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer, Inc. (US)
Bayer HealthCare Pharmaceuticals, Inc. (US)
GlaxoSmithKline (UK)
AbbVie, Inc. (US)
Anavex Life Sciences Corp. (US)
Baxter International, Inc. (US)
Biocon (India)
Eli Lilly (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Genentech (US)
Janssen Biotech, Inc. (US)
Kemwell Biopharma (India)
Novartis (Switzerland)
Sun Pharmaceutical Industries Ltd. (India)
Sanofi S.A. (France)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of  Recombinant Protein in each application, can be divided into
Application 1
Application 2
Application 3

A massive portion of the overall impetus that players and markets associated with biotechnology are receiving, comes from the rapidly increasing government support. Developed economies are especially ahead of the game in terms of research and development, as well as the incorporation of ready products into the commercial markets. However, it should be noted that the average time to market for a standard biotechnology product is exceedingly higher than conventional medical products. Despite this, players are becoming ever ready to tackle the more promising fields in biotechnology, namely stem cell technology, nanotechnology, and genetic cloning. This field is poised to be an inseparable part of the healthcare industry, and is in need of heavy efforts on the research and development side.

The United states recombinant protein market report 2016 is a very different market loaded with exceptional competitors and very specific customer and end user appeals. The improvement of innovations is additionally in high demand, with the developed economies demonstrating a more prominent consideration in the advancement of cutting edge advances than the developing economies. The report considers every such element while surveying the upcoming expected openings for players in the market over the coming years. It therefore converts the data presented into a matter of point of view, and offers the most ideal one for the market as far as getting favored by the key drivers and patterns influencing the market is concerned, while evading the hindrances that could prevent the advance of the players. The establishment for this investigation is made by getting the readers of this report familiar with the basic syntax of the market as it is important to completely comprehend its progression that the said entities are expected to promote themselves on.

The regional examination of the United states recombinant protein market report 2016 can be depicted as a widely inclusive survey of the key locations, from the points of view of these locations as specified through their existing player base and the general end user reports for them. This is a doubly useful approach in market examination for the regional companies, as it helps them see precisely what their field of operation needs, as far as their end users are concerned. Moreover, investors will be able to figure out which organization they can pay special attention to when attempting to extend their investments profiles. Additionally, the level of detail with which every segment and region is depicted can build this report up to be a convenient guide for them with regards to enhancing their place in a particular region or country, or with regards to entering new market fruitfully over the coming years.

The competitive analysis presented in the report on the United states recombinant protein market report 2016 can be an imperative device in the overall arsenal that a market player possesses. A careful learning and understanding of the competitive profiles and the contentions between players is a crucial bit of data needed by all market players, and it is the thing that this report gives to every client. The level of customization for every player takes into consideration an extraordinary standpoint for them, taking into account significantly more noteworthy data.

Table of Contents

1 Recombinant Protein Overview
1.1 Product Overview and Scope of Recombinant Protein
1.2 Classification of Recombinant Protein
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Recombinant Protein
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Recombinant Protein (2011-2021)
1.4.1 United States Recombinant Protein Sales and Growth Rate (2011-2021)
1.4.2 United States Recombinant Protein Revenue and Growth Rate (2011-2021)

2 United States Recombinant Protein Competition by Manufacturers
2.1 United States Recombinant Protein Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Recombinant Protein Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Recombinant Protein Average Price by Manufactures (2015 and 2016)
2.4 Recombinant Protein Market Competitive Situation and Trends
2.4.1 Recombinant Protein Market Concentration Rate
2.4.2 Recombinant Protein Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Recombinant Protein Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Recombinant Protein Sales and Market Share by Type (2011-2016)
3.2 United States Recombinant Protein Revenue and Market Share by Type (2011-2016)
3.3 United States Recombinant Protein Price by Type (2011-2016)
3.4 United States Recombinant Protein Sales Growth Rate by Type (2011-2016)

4 United States Recombinant Protein Sales (Volume) by Application (2011-2016)
4.1 United States Recombinant Protein Sales and Market Share by Application (2011-2016)
4.2 United States Recombinant Protein Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States Recombinant Protein Manufacturers Profiles/Analysis
5.1 Pfizer, Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Recombinant Protein Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Bayer HealthCare Pharmaceuticals, Inc. (US)
5.2.2 Recombinant Protein Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Bayer HealthCare Pharmaceuticals, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline (UK)
5.3.2 Recombinant Protein Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GlaxoSmithKline (UK) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 AbbVie, Inc. (US)
5.4.2 Recombinant Protein Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 AbbVie, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Anavex Life Sciences Corp. (US)
5.5.2 Recombinant Protein Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Anavex Life Sciences Corp. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Baxter International, Inc. (US)
5.6.2 Recombinant Protein Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Baxter International, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Biocon (India)
5.7.2 Recombinant Protein Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Biocon (India) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Eli Lilly (US)
5.8.2 Recombinant Protein Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Eli Lilly (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 F. Hoffmann-La Roche Ltd. (Switzerland)
5.9.2 Recombinant Protein Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 F. Hoffmann-La Roche Ltd. (Switzerland) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Genentech (US)
5.10.2 Recombinant Protein Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Genentech (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Janssen Biotech, Inc. (US)
5.12 Kemwell Biopharma (India)
5.13 Novartis (Switzerland)
5.14 Sun Pharmaceutical Industries Ltd. (India)
5.15 Sanofi S.A. (France)

6 Recombinant Protein Manufacturing Cost Analysis
6.1 Recombinant Protein Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Recombinant Protein

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Recombinant Protein Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Recombinant Protein Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States Recombinant Protein Market Forecast (2016-2021)
10.1 United States Recombinant Protein Sales, Revenue Forecast (2016-2021)
10.2 United States Recombinant Protein Sales Forecast by Type (2016-2021)
10.3 United States Recombinant Protein Sales Forecast by Application (2016-2021)
10.4 Recombinant Protein Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

Figure Picture of Recombinant Protein
Table Classification of Recombinant Protein
Figure United States Sales Market Share of Recombinant Protein by Type in 2015
Table Application of Recombinant Protein
Figure United States Sales Market Share of Recombinant Protein by Application in 2015
Figure United States Recombinant Protein Sales and Growth Rate (2011-2021)
Figure United States Recombinant Protein Revenue and Growth Rate (2011-2021)
Table United States Recombinant Protein Sales of Key Manufacturers (2015 and 2016)
Table United States Recombinant Protein Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Protein Sales Share by Manufacturers
Figure 2016 Recombinant Protein Sales Share by Manufacturers
Table United States Recombinant Protein Revenue by Manufacturers (2015 and 2016)
Table United States Recombinant Protein Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Recombinant Protein Revenue Share by Manufacturers
Table 2016 United States Recombinant Protein Revenue Share by Manufacturers
Table United States Market Recombinant Protein Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Recombinant Protein Average Price of Key Manufacturers in 2015
Figure Recombinant Protein Market Share of Top 3 Manufacturers
Figure Recombinant Protein Market Share of Top 5 Manufacturers
Table United States Recombinant Protein Sales by Type (2011-2016)
Table United States Recombinant Protein Sales Share by Type (2011-2016)
Figure United States Recombinant Protein Sales Market Share by Type in 2015
Table United States Recombinant Protein Revenue and Market Share by Type (2011-2016)
Table United States Recombinant Protein Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Recombinant Protein by Type (2011-2016)
Table United States Recombinant Protein Price by Type (2011-2016)
Figure United States Recombinant Protein Sales Growth Rate by Type (2011-2016)
Table United States Recombinant Protein Sales by Application (2011-2016)
Table United States Recombinant Protein Sales Market Share by Application (2011-2016)
Figure United States Recombinant Protein Sales Market Share by Application in 2015
Table United States Recombinant Protein Sales Growth Rate by Application (2011-2016)
Figure United States Recombinant Protein Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Recombinant Protein Sales Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals, Inc. (US) Basic Information List
Table Bayer HealthCare Pharmaceuticals, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Pharmaceuticals, Inc. (US) Recombinant Protein Sales Market Share (2011-2016)
Table GlaxoSmithKline (UK) Basic Information List
Table GlaxoSmithKline (UK) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline (UK) Recombinant Protein Sales Market Share (2011-2016)
Table AbbVie, Inc. (US) Basic Information List
Table AbbVie, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie, Inc. (US) Recombinant Protein Sales Market Share (2011-2016)
Table Anavex Life Sciences Corp. (US) Basic Information List
Table Anavex Life Sciences Corp. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Anavex Life Sciences Corp. (US) Recombinant Protein Sales Market Share (2011-2016)
Table Baxter International, Inc. (US) Basic Information List
Table Baxter International, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxter International, Inc. (US) Recombinant Protein Sales Market Share (2011-2016)
Table Biocon (India) Basic Information List
Table Biocon (India) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon (India) Recombinant Protein Sales Market Share (2011-2016)
Table Eli Lilly (US) Basic Information List
Table Eli Lilly (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly (US) Recombinant Protein Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Recombinant Protein Sales Market Share (2011-2016)
Table Genentech (US) Basic Information List
Table Genentech (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech (US) Recombinant Protein Sales Market Share (2011-2016)
Table Janssen Biotech, Inc. (US) Basic Information List
Table Janssen Biotech, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Biotech, Inc. (US) Recombinant Protein Sales Market Share (2011-2016)
Table Kemwell Biopharma (India) Basic Information List
Table Kemwell Biopharma (India) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kemwell Biopharma (India) Recombinant Protein Sales Market Share (2011-2016)
Table Novartis (Switzerland) Basic Information List
Table Novartis (Switzerland) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis (Switzerland) Recombinant Protein Sales Market Share (2011-2016)
Table Sun Pharmaceutical Industries Ltd. (India) Basic Information List
Table Sun Pharmaceutical Industries Ltd. (India) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceutical Industries Ltd. (India) Recombinant Protein Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Recombinant Protein Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Protein
Figure Manufacturing Process Analysis of Recombinant Protein
Figure Recombinant Protein Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Protein Major Manufacturers in 2015
Table Major Buyers of Recombinant Protein
Table Distributors/Traders List
Figure United States Recombinant Protein Production and Growth Rate Forecast (2016-2021)
Figure United States Recombinant Protein Revenue and Growth Rate Forecast (2016-2021)
Table United States Recombinant Protein Production Forecast by Type (2016-2021)
Table United States Recombinant Protein Consumption Forecast by Application (2016-2021)

Request a Sample Copy

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top